215 related articles for article (PubMed ID: 12084717)
1. Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.
Taggart CC; Greene CM; McElvaney NG; O'Neill S
J Biol Chem; 2002 Sep; 277(37):33648-53. PubMed ID: 12084717
[TBL] [Abstract][Full Text] [Related]
2. Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
Taggart CC; Cryan SA; Weldon S; Gibbons A; Greene CM; Kelly E; Low TB; O'neill SJ; McElvaney NG
J Exp Med; 2005 Dec; 202(12):1659-68. PubMed ID: 16352738
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation.
Lentsch AB; Jordan JA; Czermak BJ; Diehl KM; Younkin EM; Sarma V; Ward PA
Am J Pathol; 1999 Jan; 154(1):239-47. PubMed ID: 9916938
[TBL] [Abstract][Full Text] [Related]
4. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
Mukhopadhyay A; Manna SK; Aggarwal BB
J Biol Chem; 2000 Mar; 275(12):8549-55. PubMed ID: 10722693
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor.
Mulligan MS; Lentsch AB; Huber-Lang M; Guo RF; Sarma V; Wright CD; Ulich TR; Ward PA
Am J Pathol; 2000 Mar; 156(3):1033-9. PubMed ID: 10702419
[TBL] [Abstract][Full Text] [Related]
6. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
Uehara T; Matsuno J; Kaneko M; Nishiya T; Fujimuro M; Yokosawa H; Nomura Y
J Biol Chem; 1999 May; 274(22):15875-82. PubMed ID: 10336492
[TBL] [Abstract][Full Text] [Related]
7. Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells.
Greene CM; McElvaney NG; O'Neill SJ; Taggart CC
Infect Immun; 2004 Jun; 72(6):3684-7. PubMed ID: 15155685
[TBL] [Abstract][Full Text] [Related]
8. Effects of secretory leukocyte protease inhibitor on the tumor necrosis factor-alpha production and NF-kappaB activation of lipopolysaccharide-stimulated macrophages.
Sano C; Shimizu T; Tomioka H
Cytokine; 2003 Jan; 21(1):38-42. PubMed ID: 12668158
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli.
Henriksen PA; Hitt M; Xing Z; Wang J; Haslett C; Riemersma RA; Webb DJ; Kotelevtsev YV; Sallenave JM
J Immunol; 2004 Apr; 172(7):4535-44. PubMed ID: 15034071
[TBL] [Abstract][Full Text] [Related]
10. Differential IkappaB kinase activation and IkappaBalpha degradation by interleukin-1beta and tumor necrosis factor-alpha in human U937 monocytic cells. Evidence for additional regulatory steps in kappaB-dependent transcription.
Nasuhara Y; Adcock IM; Catley M; Barnes PJ; Newton R
J Biol Chem; 1999 Jul; 274(28):19965-72. PubMed ID: 10391945
[TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice.
Nakamura A; Mori Y; Hagiwara K; Suzuki T; Sakakibara T; Kikuchi T; Igarashi T; Ebina M; Abe T; Miyazaki J; Takai T; Nukiwa T
J Exp Med; 2003 Mar; 197(5):669-74. PubMed ID: 12615907
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-induced NF-kappaB activation in human endothelial cells involves degradation of IkappaBalpha but not IkappaBbeta.
Zen K; Karsan A; Eunson T; Yee E; Harlan JM
Exp Cell Res; 1998 Sep; 243(2):425-33. PubMed ID: 9743602
[TBL] [Abstract][Full Text] [Related]
13. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.
Roff M; Thompson J; Rodriguez MS; Jacque JM; Baleux F; Arenzana-Seisdedos F; Hay RT
J Biol Chem; 1996 Mar; 271(13):7844-50. PubMed ID: 8631829
[TBL] [Abstract][Full Text] [Related]
14. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis.
Page S; Fischer C; Baumgartner B; Haas M; Kreusel U; Loidl G; Hayn M; Ziegler-Heitbrock HW; Neumeier D; Brand K
J Biol Chem; 1999 Apr; 274(17):11611-8. PubMed ID: 10206970
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
Han Y; Weinman S; Boldogh I; Walker RK; Brasier AR
J Biol Chem; 1999 Jan; 274(2):787-94. PubMed ID: 9873017
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.
McNeely TB; Shugars DC; Rosendahl M; Tucker C; Eisenberg SP; Wahl SM
Blood; 1997 Aug; 90(3):1141-9. PubMed ID: 9242546
[TBL] [Abstract][Full Text] [Related]
17. Effect of proteasome inhibitors on monocytic IkappaB-alpha and -beta depletion, NF-kappaB activation, and cytokine production.
Haas M; Page S; Page M; Neumann FJ; Marx N; Adam M; Ziegler-Heitbrock HW; Neumeier D; Brand K
J Leukoc Biol; 1998 Mar; 63(3):395-404. PubMed ID: 9500529
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor.
Taggart CC; Lowe GJ; Greene CM; Mulgrew AT; O'Neill SJ; Levine RL; McElvaney NG
J Biol Chem; 2001 Sep; 276(36):33345-52. PubMed ID: 11435427
[TBL] [Abstract][Full Text] [Related]
19. Enhanced proteolysis of IkappaBalpha and IkappaBbeta proteins in astrocytes by Moloney murine leukemia virus (MoMuLV)-ts1 infection: a potential mechanism of NF-kappaB activation.
Kim HT; Qiang W; Wong PK; Stoica G
J Neurovirol; 2001 Oct; 7(5):466-75. PubMed ID: 11582519
[TBL] [Abstract][Full Text] [Related]
20. Elafin prevents lipopolysaccharide-induced AP-1 and NF-kappaB activation via an effect on the ubiquitin-proteasome pathway.
Butler MW; Robertson I; Greene CM; O'Neill SJ; Taggart CC; McElvaney NG
J Biol Chem; 2006 Nov; 281(46):34730-5. PubMed ID: 16980310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
